US 10035845
Neutralizing antibodies to HIV-1 and their use
granted A61KA61K39/42A61K45/06
Quick answer
US patent 10035845 (Neutralizing antibodies to HIV-1 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K39/42, A61K45/06, A61P, A61P31/18